← All trials
NCT06052436
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 27, 2023
- Primary completion
- Dec 31, 2027
- Completion date
- Dec 31, 2027
- First posted
- Sep 25, 2023
- Last posted
- Sep 25, 2023
- Enrollment
- 24
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hospital General Universitario Gregorio MarañonLead sponsor
- Hospital General Universitario Gregorio MarañonOverall official - principal investigator
- Hospital General Universitario Gregorio MarañonReponsible party - principal investigator
- Universidad Carlos III MadridCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.